PMC:7600245 / 21329-21389 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T156","span":{"begin":0,"end":60},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tenofovir alafenamide was first approved in 2016 by the U.S."}

{"project":"LitCovid-PubTator","denotations":[{"id":"569","span":{"begin":0,"end":21},"obj":"Chemical"}],"attributes":[{"id":"A569","pred":"tao:has_database_id","subj":"569","obj":"MESH:C442442"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Tenofovir alafenamide was first approved in 2016 by the U.S."}